Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Patient Derived Xenograft/PDX Models
... estimated at US$115.7 Million in the year 2020, is projected to reach a revised size of US$333.2 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mice Model, one of the segments ... Read More
-
Liver Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Cholangio Carcinoma, Hepatocellular Carcinoma, Hepatoblastoma, Others); By Treatment Type; By Region; Segment Forecast, 2022 - 2030
... to reach USD 10.48 billion by 2030, according to a new study by Polaris Market Research. The report “Liver Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Cholangio Carcinoma, Hepatocellular Carcinoma, Hepatoblastoma, Others); ... Read More
-
Lung Cancer Screening Market By Type (Low-dose computed tomography (LDCT), X-ray), By Age group (50 and older, Below 50), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... lung cancer screening market was valued at $879.59 million in 2021, and is projected to reach $1,853.04 million by 2031, registering a CAGR of 7.7% from 2022 to 2031. Lung cancer screening refers to methods ... Read More
-
Europe Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Europe Lung Cancer Surgery Market, By Product Type ... Read More
-
APAC Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Asia-Pacific Lung Cancer Surgery Market, By Product ... Read More
-
Uterine Cancer Therapeutics & Diagnostics
... at US$18.4 Billion in the year 2020, is projected to reach a revised size of US$24.3 Billion by 2027, growing at aCAGR of 4.1% over the period 2020-2027. Endometrial Carcinomas, one of the segments analyzed ... Read More
-
NA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029. Market Segmentation North America Hereditary Cancer Testing Market, By Test ... Read More
-
Women's Health Diagnostics
... 2020, is projected to reach a revised size of US$35.9 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Breast Cancer Testing, one of the segments analyzed in the report, ... Read More
-
Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, By Type (Epithelial Tumors, Germ Cell Tumors, Stromal Tumors, and Primary Peritoneal Cancer); By Diagnosis; By Therapeutic Treatment; By End-User; By Region; Segment Forecast, 2022 - 203
... 2030 The global ovarian cancer market is expected to reach USD 9.67 billion by 2030, according to a new study by Polaris Market Research. The report “Ovarian Cancer Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others); By Diagnosis; By Cancer Type, By End-Users; By Region; Segment Forecast, 2022 - 2030
... global pancreatic cancer market size is expected to reach USD 7.04 million by 2030, according to a new study by Polaris Market Research. The report “Pancreatic Cancer Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
NA Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation North America Lung Cancer Surgery Market, By ... Read More
-
Primary Immunodeficiency Diseases
... 2020, is projected to reach a revised size of US$10.4 Billion by 2027, growing at a CAGR of 6.4% over the analysis period 2020-2027. Antibody Deficiency, one of the segments analyzed in the report, is ... Read More
-
PD-1 and PD-L1 Inhibitors- Competitive Landscape, 2022
... therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage PD-1 AND PD-L1 Inhibitors: Understanding PD-1 AND PD-L1 ... Read More
-
Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape. Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. ... Read More
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Global Cutaneous Squamous Cell Carcinoma Market - 2022-2029
... a CAGR of 7.2 % during the forecast period (2022-2029). Cancer starts in the cells that make up the epidermis (the outer layer of the skin). It commonly develops in parts of the skin that ... Read More
-
Global Artificial Intelligence (AI) in Oncology Market Size study, by Treatment (Hemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy, And Others) by Type (Lung Cancer, Breast Cancer, Melanoma Cancer, Prostate Cancer, Colorectal Cancer, Among Others), by Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028
... Application (Diagnosis, Therapy, Prognosis, Health Management, Research) and Regional Forecasts 2022-2028 Global Artificial Intelligence (AI) in Oncology Market is valued at approximately USD XX Million in 2021 and is anticipated to grow with a healthy ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral T-Cell Lymphomas (PTCL) Clinical trials scenario. This report provides top line data ... Read More
-
Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
... is expected to grow from US$ 3,864.66 million in 2022 to US$ 5,169.04 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028. The growing pharmaceutical industry in ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer ... Read More
-
Asia Pacific Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The APAC human ... Read More
-
Europe Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The Europe human papillomavirus ... Read More
-
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others)
... 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-based Health Centers, Health Departments, Hospitals, and Others) The ... Read More
-
South America Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (9-valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)
... Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and End User (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others) The South America ... Read More
Research Assistance
